Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azim Mohamedali

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
British Journal of Haematology|November 20, 2008
Van-den Berghe's 5q- syndrome in 2008Azim Mohamedali, Ghulam J Mufti
Cancer Immunology, Immunotherapy : CII|December 21, 2006
Immunotherapy of myeloid leukaemiaBarbara-Ann Guinn, Azim Mohamedali, N Shaun B Thomas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2004
Self-inactivating lentiviral vectors resist proviral methylation but do not confer position-independent expression in hematopoietic stem cellsAzim Mohamedali, Francois Moreau-Gaudry, Emmanuel Richard, et al.
British Journal of Haematology|November 20, 2008
Serum profiling reveals distinctive proteomic markers in chronic myeloid leukaemia patientsAzim Mohamedali, Barbara-ann Guinn, Satyajit Sahu, et al.
Cancer Research|January 22, 2017
FLT3 and JAK2 Mutations in Acute Myeloid Leukemia Promote Interchromosomal Homologous Recombination and the Potential for Copy Neutral Loss of HeterozygosityTerry J Gaymes, Azim Mohamedali, Anthony L Eiliazadeh, et al.
British Journal of Haematology|November 20, 2020
Uniparental disomy (UPD) of a novel bisphosphoglycerate mutase (BPGM) mutation leading to erythrocytosisIoanna Lazana, Azim Mohamedali, Frances Smith, et al.
Biomarker Insights|August 8, 2009
Leukemia associated antigens: their dual role as biomarkers and immunotherapeutic targets for acute myeloid leukemiaBarbara-Ann Guinn, Azim Mohamedali, Ken I Mills, et al.
Technology in Cancer Research & Treatment|September 12, 2008
AKT1 (E17K) mutation in pancreatic cancerAzim Mohamedali, Nicholas C Lea, Roger M Feakins, et al.
Journal of Leukocyte Biology|November 13, 2003
Cyclin D2 controls B cell progenitor numbersAzim Mohamedali, Inês Soeiro, Nicholas C Lea, et al.
The Lancet. Haematology|December 22, 2015
CSNK1A1 mutations and isolated del(5q) abnormality in myelodysplastic syndrome: a retrospective mutational analysisAlexander E Smith, Austin G Kulasekararaj, Jie Jiang, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|November 20, 2008
Van-den Berghe's 5q- syndrome in 2008Azim Mohamedali, Ghulam J Mufti
Cancer Immunology, Immunotherapy : CII|December 21, 2006
Immunotherapy of myeloid leukaemiaBarbara-Ann Guinn, Azim Mohamedali, N Shaun B Thomas, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2004
Self-inactivating lentiviral vectors resist proviral methylation but do not confer position-independent expression in hematopoietic stem cellsAzim Mohamedali, Francois Moreau-Gaudry, Emmanuel Richard, et al.
British Journal of Haematology|November 20, 2008
Serum profiling reveals distinctive proteomic markers in chronic myeloid leukaemia patientsAzim Mohamedali, Barbara-ann Guinn, Satyajit Sahu, et al.
Cancer Research|January 22, 2017
FLT3 and JAK2 Mutations in Acute Myeloid Leukemia Promote Interchromosomal Homologous Recombination and the Potential for Copy Neutral Loss of HeterozygosityTerry J Gaymes, Azim Mohamedali, Anthony L Eiliazadeh, et al.
British Journal of Haematology|November 20, 2020
Uniparental disomy (UPD) of a novel bisphosphoglycerate mutase (BPGM) mutation leading to erythrocytosisIoanna Lazana, Azim Mohamedali, Frances Smith, et al.
Biomarker Insights|August 8, 2009
Leukemia associated antigens: their dual role as biomarkers and immunotherapeutic targets for acute myeloid leukemiaBarbara-Ann Guinn, Azim Mohamedali, Ken I Mills, et al.
Technology in Cancer Research & Treatment|September 12, 2008
AKT1 (E17K) mutation in pancreatic cancerAzim Mohamedali, Nicholas C Lea, Roger M Feakins, et al.
Journal of Leukocyte Biology|November 13, 2003
Cyclin D2 controls B cell progenitor numbersAzim Mohamedali, Inês Soeiro, Nicholas C Lea, et al.
The Lancet. Haematology|December 22, 2015
CSNK1A1 mutations and isolated del(5q) abnormality in myelodysplastic syndrome: a retrospective mutational analysisAlexander E Smith, Austin G Kulasekararaj, Jie Jiang, et al.
Pageof 2